- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05918679
The Brain Processes Underlying Speech Motor Learning and Speech Production
July 18, 2023 updated by: Arizona State University
Improving Speech Motor Learning Processes Using Augmented Behavioral Interventions
The aim of this research is to develop protocols that selectively target and improve speech-motor learning processes.
Participants will be asked to name pictures, read words/sentences, and listen to sounds while their speech signals will be collected during the study.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
- Behavioral: Effects of speech variability on speech motor learning
- Behavioral: Effects of error-detection training on speech motor learning
- Behavioral: Contributions of error awareness to speech motor learning
- Behavioral: Enhancing auditory-to-motor mapping with augmented visual feedback
- Behavioral: Effects of enhanced auditory-motor awareness on speech motor learning
Study Type
Interventional
Enrollment (Estimated)
510
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ayoub Daliri
- Phone Number: 4807278397
- Email: ayoub.daliri@asu.edu
Study Locations
-
-
Arizona
-
Tempe, Arizona, United States, 85287
- Recruiting
- Arizona State University
-
Contact:
- Ayoub Daliri
- Phone Number: 480-727-8397
- Email: ayoub.daliri@asu.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Study Population
We accept healthy adult subjects older than 18.
The studies will be conducted at Arizona State University.
Description
Inclusion Criteria:
- 18 years and older
- native speaker of American English
- normal (age-appropriate) binaural pure-tone hearing threshold
- not taking medications affecting sensorimotor functioning
- no current or history of communication, neurological, or psychological disorders
Exclusion Criteria:
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Healthy Adults group 1
|
This intervention will examine whether reducing normal variability of speech could improve error detection and speech motor learning.
We will design training tasks to change subjects' speech variability.
We will train subjects to decrease/decrease their speech variability.
Upon completing the training tasks, subjects will complete a motor learning task.
|
Experimental: Healthy Adults group 2
|
This intervention will examine whether improving subjects' ability to detect and estimate auditory perturbation could improve speech motor learning.
For this purpose, we will design training tasks to change subjects' estimation of the perturbation magnitude.
After completing the training tasks, subjects will complete the motor learning task.
|
Experimental: Healthy Adults group 3
|
This intervention will examine the contributions of error awareness to speech motor learning.
Subjects will produce a target word while receiving perturbed auditory feedback with different magnitudes.
Subjects will be trained to indicate the magnitude of the error they perceived with or without visual feedback.
|
Experimental: Healthy Adults group 4
|
This intervention will determine the contributions of enhanced auditory-to-motor mappings to speech motor learning.
We will design training tasks in which we will use visual feedback to provide feedback regarding subjects' accuracy of auditory-to-motor mapping.
|
Experimental: Healthy Adults group 5
|
In this intervention, subjects will be trained to control their articulators more accurately and be more aware of their articulators' position and their auditory consequences.
After the training tasks, subjects will complete a motor learning task.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in speech output in response to previously experienced auditory errors
Time Frame: within each session of the study that may last up to 2 hours
|
In each trial, participants will experience an auditory error while they produce speech (e.g., they may say "head" but hear "had").
Participants' speech will be measured in each trial.
The investigators will measure how the participants' speech changes due to auditory errors experienced in previous trials.
|
within each session of the study that may last up to 2 hours
|
Change In Speech Output Immidiately After Hearing Auditory Errors
Time Frame: within each session of the study that may last up to 2 hours
|
In each trial, participants will experience an auditory error while they produce speech (e.g., they may say "head" but hear "had").
The investigators will measure how the participants' speech changes due to auditory errors that they experience in the current trial.
|
within each session of the study that may last up to 2 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2023
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
August 1, 2026
Study Registration Dates
First Submitted
June 5, 2023
First Submitted That Met QC Criteria
June 14, 2023
First Posted (Actual)
June 26, 2023
Study Record Updates
Last Update Posted (Actual)
July 19, 2023
Last Update Submitted That Met QC Criteria
July 18, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- STUDY00017657
- R01DC019905 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Adults
-
KU LeuvenCompletedHealthy Older Adults | Ill Older AdultsBelgium
-
Samsung Medical CenterTerminatedHealthy Aging | Healthy AdultsKorea, Republic of
-
Lumos Labs, Inc.Not yet recruitingHealthy AdultsUnited States
-
Shirley Ryan AbilityLabNot yet recruiting
-
National Institute of Allergy and Infectious Diseases...RecruitingHealthy AdultsUnited States
-
Marian NeuhouserDuke University; University of Washington; University of Nebraska; United States...Recruiting
-
Mirati Therapeutics Inc.CompletedHealthy AdultsUnited States
-
Ohio State UniversityActive, not recruitingHealthy AdultsUnited States
-
Ohio State UniversityActive, not recruitingHealthy AdultsUnited States
-
Canopy Growth CorporationCompleted
Clinical Trials on Effects of speech variability on speech motor learning
-
University of Wisconsin, MadisonOffice of the Vice Chancellor for Research and Graduate Education; Wisconsin...Completed
-
University of Missouri-ColumbiaNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedParkinson Disease | Amyotrophic Lateral SclerosisUnited States
-
Milton S. Hershey Medical CenterPenn State University; Congressionally Directed Medical Research ProgramsRecruiting
-
Universita di VeronaCompletedPsoriasis VulgarisItaly
-
University of Massachusetts, WorcesterGlaxoSmithKlineCompletedMetabolic Syndrome | Insulin ResistanceUnited States
-
Bristol-Myers SquibbCompletedPsoriasis VulgarisUnited States
-
Bristol-Myers SquibbHexor, South AfricaCompleted
-
Haukeland University HospitalRecruiting
-
Bristol-Myers SquibbCompletedRheumatoid ArthritisUnited States, Netherlands, Belgium, Canada, Germany, France, Ireland, Switzerland, United Kingdom
-
Arthritis & Rheumatic Disease Specialties ResearchBristol-Myers SquibbCompletedRheumatoid ArthritisUnited States